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Background: Several studies have correlated elevations in cardiac biomarkers of injury post marathon with
transient and reversible right ventricular (RV) systolic dysfunction as assessed by both transthoracic
echocardiography (TTE) and cardiovascular magnetic resonance (CMR). Whether or not permanent myocardial
injury occurs due to repeated marathon running in the aging population remains controversial.
Objectives: To assess the extent and severity of cardiac dysfunction after the completion of full marathon running
in individuals greater than 50 years of age using cardiac biomarkers, TTE, cardiac computed tomography (CCT),
and CMR.
Methods: A total of 25 healthy volunteers (21 males, 55 ± 4 years old) from the 2010 and 2011 Manitoba Full
Marathons (26.2 miles) were included in the study. Cardiac biomarkers and TTE were performed one week prior to
the marathon, immediately after completing the race and at one-week follow-up. CMR was performed at baseline
and within 24 hours of completion of the marathon, followed by CCT within 3 months of the marathon.
Results: All participants demonstrated an elevated cTnT post marathon. Right atrial and ventricular volumes
increased, while RV systolic function decreased significantly immediately post marathon, returning to baseline
values one week later. Of the entire study population, only two individuals demonstrated late gadolinium
enhancement of the subendocardium in the anterior wall of the left ventricle, with evidence of stenosis of the left
anterior descending artery on CCT.
Conclusions: Marathon running in individuals over the age of 50 is associated with a transient, yet reversible
increase in cardiac biomarkers and RV systolic dysfunction. The presence of myocardial fibrosis in older marathon
athletes is infrequent, but when present, may be due to underlying occult coronary artery disease.
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Participation in strenuous aerobic physical activity is on
the rise in North America, especially among the aging
population [1]. The cardiovascular effects of acute strenu-
ous exercise, specifically marathon running, has been stud-
ied extensively over the past two decades [2-5]. A number
of studies involving marathon participants between the
ages of 18 and 40 years, have demonstrated a transient in-
crease in cardiac biomarkers and right ventricular (RV)
systolic dysfunction using multimodality cardiac imaging,
including transthoracic echocardiography (TTE) and car-
diovascular magnetic resonance (CMR) [6-12]. Little is
known, however, on the cardiovascular effects of repeated
marathon running in individuals over the age of 50.
Although cardiac biomarkers, including cardiac specific
TnT, are transiently elevated in participants immediately
following the marathon [6-12], it remains unclear whether
true myocardial necrosis occurs at the cellular level. Late
gadolinium enhancement CMR (LGE-CMR), following ad-
ministration of gadolinium, has been recently evaluated as
a noninvasive method of delineating myocardial necrosis
in this patient population [11-16]. In individuals between
the ages of 18 and 40, a number of recent marathon stud-
ies have demonstrated the absence of LGE of the left ven-
tricular (LV) myocardium [11,12,15,16]. This would
suggest that permanent myocardial injury does not occur
from repeated marathon running.
On the contrary, Breuckmann et al. recently demon-
strated evidence of LGE of the LV myocardium in a hetero-
geneous cohort of individuals greater than 50 years of age,
suggesting myocardial injury may result from the stress of
repeated marathon running [14]. In their study, a greater
number of participants who ran marathons demonstrated
LGE of the LV myocardium when compared to age-
matched controls. Although the study excluded runners
with a preceding history of ischemic heart disease (IHD),
the presence of obstructive coronary artery disease (CAD)
was not systematically evaluated. It is entirely plausible that
the LGE of the LV myocardium observed in the runners
greater than 50 years of age in their patient population may
have been due to underlying occult obstructive CAD, rather
than as a direct result of repetitive marathon running.
The aims of the current study were two-fold: 1) To as-
sess the extent and severity of cardiac dysfunction after the
completion of full marathon running in elite individuals
>50 years of age using cardiac biomarkers, TTE and CMR;
and 2) If there is evidence of LGE on CMR, to detect the




A prospective study was performed on 25 consecutive elite
individuals who participated in the 2010 and 2011Manitoba Full Marathons. Subjects over the age of 50 who
participated in greater than three marathons in the past
two years, were included in the study. Exclusion criteria
included a history of smoking, hypertension, elevated
lipids, diabetes, and/or contraindications for CCT or CMR.
The study protocol was approved by the local institutional
review board.
Cardiac biomarkers
The cardiac biomarkers measured included myoglobin,
creatinine kinase (CK), and cardiac specific troponin T
(cTnT). These biomarkers were measured at three separate
time points: (1) 1 week prior to the marathon; (2) immedi-
ately after completion of the full marathon; and (3) 1 week
following the marathon. Myoglobin levels were determined
using a RocheTM Elecsys analyzer and CK levels were
determined using a RocheTM 917 analyzer. An increase in
myoglobin and CK levels four times greater than baseline
was considered elevated. A third generation Roche Elecsys
assay was used to perform quantitative determinations of
cTnT levels.
Echocardiography
All subjects underwent baseline TTE one week prior to the
marathon, immediately after completion of the marathon
and one week post marathon. Parasternal and apical views
were obtained using a standard echocardiography machine
(GE Vivid 7, Milwaukee, Il, USA) with a multifrequency
transducer and tissue Doppler capability. Standard 2-
dimensional images, M-mode, spectral and color Doppler,
and tissue Doppler imaging (TDI) were performed.
Interventricular septal thickness (IVS), posterior wall
thickness (PWT), left ventricular ejection fraction (LVEF),
and left atrial (LA) size indexed to body surface area were
determined from 2-dimensional images [17]. Left ventricu-
lar mass was calculated using the area-length method per
the American Society of Echocardiography guidelines [17].
Right ventricular cavity dimensions, RV fractional area
change (FAC) and tricuspid annular plane systolic excur-
sion (TAPSE) were determined [18]. Continuous-wave
Doppler was used to measure the peak velocity across the
tricuspid valve and the maximal peak pressure gradient
was estimated using the simplified Bernouilli equation with
addition of the right atrial pressure to calculate the pul-
monary artery systolic pressure (PASP) [18]. Transmitral
LV filling velocity at the tips of the mitral valve leaflets
were obtained from the apical 4-chamber view using
pulsed wave Doppler echocardiography. Tissue Doppler
derived indices were recorded at the lateral mitral annulus
of the LV and the lateral tricuspid annulus of the RV.
Cardiac computed tomography
All patients underwent CCT using a 64 detector-row GE
Lightspeed VCT scanner (General Electric Medical
Table 1 Patient clinical characteristics (n = 25)
Characteristics Baseline Post-race




Weight (kg) 68±9 68±8
Height (cm) 169±8 169±8
BMI (kg/m2) 24±2 24±2
Heart rate (bpm) 63±11 95±8
SBP (mm Hg) 128±11 114±12
DBP (mm Hg) 72±5 67±6
Values are mean ± SD. y, years; BMI, body mass index; bpm, beats per minute;
SBP, systolic blood pressure; DBP, diastolic blood pressure.
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completing the full marathon. A prospective ECG-gated
(SnapShot Pulse, GE Medical) CT coronary angiogram was
performed. Images were obtained with a tube rotation time
of 0.35 sec, 120 kV and 0.625 mm thick contiguous images
through the coronary arteries with a field of view to cover
the heart (Cardiac Medium, GE Medical) and cardiac
phase coverage of 70-80%. All images were reviewed on a
3D workstation (GE Advantage, General Electric Medical
Systems, Milwaukee, Wi, US) equipped with a dedicated
cardiac CT software package (SmartScore and CardIQ Ex-
press, GE Medical). Source images for the CT angiogram
were analyzed along with multiplanar reformations, curved
planar reformations of each coronary artery, and double
oblique reformations of each vessel axial to the lumen
throughout its course.
Cardiovascular magnetic resonance
CMR was performed on all study participants at baseline
and within 12 hours following completion of the full mara-
thon using a 1.5-T scanner (Avanto; Siemens Medical Solu-
tions, Erlangen, Germany). Breath-hold cine imaging was
performed using a segmented TrueFISP sequence with
ECG gating to achieve 25 images covering the entire car-
diac cycle. To evaluate for myocardial edema, IR-prepared
dark blood T2-weighted turbo spin echo short axis images
were obtained (TR 1800–2100 ms, TE 74 ms, 8 mm slice
thickness, 4 mm interslice gap, matrix 256 X 175). Late
gadolinium enhancement images were obtained after
10 minutes of 0.2 mmol/kg injection of Gadolinium (Gd-
DTPA, Magnevist, Schering, Germany) using a T1-
weighted IR-prepared multislice TurboFLASH sequence
with magnitude and phase sensitive reconstruction. Images
were acquired sequentially in the short axis, followed by
horizontal and vertical long axis images (TR 700 ms, TE
3.36 ms, FA 25°, 8 mm slice thickness, 1.6 mm interslice
gap, matrix 256× 192). The CMR images were analyzed
using CMR42 (Release 2.2.0, Circle Cardiovascular Imaging,
Calgary, Alberta, Canada). Endocardial and epicardial con-
tours were drawn manually for the LV and RV, respectively,
at end-systole and end-diastole in each data set with the
most basal short axis slice identified as the image which
contains at least 50% of circumferential myocardium. Pap-
illary muscles and trabeculations were included in LV and
RV mass calculation. All TTE, CCT and CMR images were
analyzed by two experienced reviewers (IK and DJ) blinded
to the clinical data.
Statistics
The data are summarized as mean±SD, number (percent-
age), or median and interquartile range. Paired Student’s
t-tests were used to compare continuous variables. Chi-
square and Fisher’s exact tests were applied to compare
categorical variables. One-way analysis of variance(nonparametric with Dunn testing) was used to compare
baseline, immediate, and one week post marathon cardiac
biomarkers and echocardiographic values. A p-value <0.05
was considered statistically significant. SAS version 9.02
(SAS Institute Inc., Cary, North Carolina) was used to
perform the analysis.
Results
In 2010 and 2011, a total of 1393 individuals (998 males)
participated in the Full Manitoba Marathons, completing
the race with an average time of 259±42 minutes. Our
study population included 25 individuals (21 males,
55±4 years) over the age of 50 who had completed 3 or
more marathons in the past two years, with a mean 57±8
marathons participated to date. All patients were moder-
ately to highly trained with a mean 47±7 miles/week. The
mean completion time of our study population was
252±33 minutes. The weights, heights and body mass in-
dices of the subjects did not change significantly after the
full marathon (Table 1).
At baseline, one week prior to the marathon, plasma
levels of cardiac biomarkers including myoglobin, CK and
cTnT were all within normal limits. Subsequently, each pa-
tient demonstrated a significant increase in each biomarker
level immediately following the marathon (Table 2). Myo-
globin levels increased from a median of 42 mg/L at base-
line to 690 mg/L immediately following the marathon. CK
levels increased from 125 U/L at baseline to 752 U/L. Fi-
nally, cTnT levels increased from <0.01 μg/L at baseline to
a median of 0.52 μg/L immediately after the race. One
week post marathon, myoglobin, CK and cTnT levels
returned to baseline values (Table 2).
Using TTE and CMR, RV structure and function chan-
ged significantly from baseline to immediately after the
marathon (Tables 3 and 4). There was an increase in right
atrial volume and RV end-diastolic diameter, with a de-
crease in RV FAC and TAPSE immediately post marathon
(Table 3). The RV TDI parameters including S’ and E’
Table 2 Cardiac biomarker data for study population at baseline and post marathon (n= 25)
Characteristics Baseline Immediately post race 1 wk post marathon
Myoglobin (mg/L) 42 (27–90) 690 (416–1832)* 72 (50–101)
CK (U/l) 125 (96–185) 752 (445–1829)* 165 (103–375)
cTnT (ug/L) <0.01 0.52 (0.38-0.81)* <0.01
Data are expressed as median (interquartile range).
*p < 0.05, after the race vs. baseline.
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abnormal at one week of follow-up (Table 4). Similarly,
CMR demonstrated an in increase in RV end-diastolic vol-
ume and a decrease in RVEF following the marathon
(Table 5). There was an increase in peak pulmonary arterial
systolic pressure from 14±3 mm Hg at baseline to
44±6 mm Hg following the race. At one week post mara-
thon, RV volumes and function by both TTE and CMR
had returned to baseline values.
Of the total study population, 23 individuals demon-
strated no evidence of myocardial edema and no LGE of
the LV myocardium using CMR, either before or after the
marathon. There was no evidence of obstructive CAD on
CCT in these 23 subjects. Two participants, however,
demonstrated LGE of the sub-endocardial layer of the an-
terior wall of the LV at baseline, with no change following
completion of the marathon (Figure 1A). TheTable 3 Echocardiographic data in study population at
baseline and post marathon (n= 25)
Echo parameters Baseline Post-race Follow-up p-value
LV parameters (2D TTE)
LVEDD (mm) 50 ± 3 51 ± 5 50 ± 4 0.93
LVESD (mm) 33 ± 5 34 ± 4 32 ± 5 0.82
LVEDV (ml) 114 ± 12 110 ± 10 112 ± 11 0.72
LVESV (ml) 39 ± 11 38 ± 13 40 ± 11 0.77
IVS (mm) 9 ± 2 9 ± 1 9 ± 2 0.82
PWT (mm) 9 ± 1 8 ± 2 9 ± 2 0.71
LVEF (%) 63 ± 4 62 ± 6 64 ± 3 0.79
LV mass/BSA (g/m2) 102 ± 11 103 ± 15 99 ± 17 0.49
LA parameters (2D TTE)
LA diameter (mm) 36 ± 4 37 ± 3 36 ± 5 0.66
LA volume (ml) 42 ± 11 44 ± 13 40 ± 13 0.44
RA and RV parameters (2D TTE)
RA volume (ml) 37 ± 12 61 ± 12 31 ± 13 0.01*
RVEDD (mm) 27 ± 3 45 ± 2 32 ± 4 0.02*
RV FAC (%) 48 ± 3 29 ± 6 49 ± 4 0.01*
TAPSE (mm) 2.3 ± 0.4 1.4 ± 0.2 2.1 ± 0.3 0.02*
Data are expressed as mean ± SD. *p < 0.05, after the race vs. baseline.
2D, 2 dimensional; TTE, transthoracic echocardiography; LVEDD,
LV end-diastolic diameter; LVESD, LV end-systolic diameter; LVEDV,
LV end-diastolic volume; LVESV, LV end-systolic volume; IVS, interventricular
septum; PWT, posterior wall thickness; LVEF, LV ejection fraction; BSA, body
surface area; LA, left atrium; RA, right atrium; RVEDD, RV end-diastolic
diameter; FAC, fractional area change; TAPSE, tricuspid annular plane
systolic excursion.corresponding CCT in these two individuals demonstrated
greater than 70% stenosis of the left anterior descending
artery (Figure 1B).
Discussion
Our study confirmed a transient but reversible increase in
cardiac biomarkers in individuals over the age of 50, fol-
lowing completion of a full marathon. While LV structure
and function was not altered acutely following strenuous
exercise, we observed a decrease in RV systolic function
confirmed by both TTE and CMR, which normalized one-
week post marathon. There was no evidence of LGE of the
LV on CMR in the majority of study participants, suggest-
ing that permanent myocardial injury does not occur due
to the stress of repeated marathon running in older indivi-
duals. In the two individuals with LGE of the LV in a sub-
endocardial distribution at baseline, the myocardial injury
was most likely due to underlying CAD.
Multiple studies have demonstrated a transient increase
in cardiac biomarkers of injury and acute RV systolic dys-
function following marathon running in younger indivi-
duals (18–40 years) [6-9,11,12,15]. While increased RA
and RV dimensions and decreased RV systolic function has
been confirmed on both TTE and CMR in youngerTable 4 Conventional and novel diastolic echo
parameters in patient population (n= 25)
Echo parameters Baseline Post-race Follow-up p value
Doppler echocardiography
Mitral E velocity (cm/s) 0.8±0.2 0.5±0.3 0.8±0.2 0.76
Mitral A velocity (cm/s) 0.5±0.1 0.5±0.2 0.5±0.2 0.68
Mitral E/A ratio 1.6±0.2 1.5±0.1 1.6±0.1 0.72
Mitral E decel time (ms) 208±52 212±63 214±48 0.65
Left Ventricle: Tissue Doppler imaging
Lateral S’ (cm/s) 10.1±1.0 10.2±0.3 10.4±1.0 0.58
Lateral E’ (cm/s) 11.4±0.6 7.6±1.1* 10.1±0.7** <0.01
Lateral A’ (cm/s) 4.2±1.2 8.2±1.0* 6.1±1.1** <0.01
Right Ventricle: Tissue Doppler imaging
S’ at base (cm/s) 11.3±0.9 8.7±1.2* 11.0±0.9 <0.01
E’ at base (cm/s) 11.6±1.0 9.5±0.9* 10.3±0.5** <0.01
A’ at base (cm/s) 7.8 ±1.1 10.3±0.9* 9.8±0.4** <0.01
Values are mean ± SD. E, early diastolic filling; A, late diastolic filling; decel,
deceleration time; S’, systolic annular velocity; E’, early diastolic annular
velocity; A’, late diastolic annular velocity. *Post-race compared to baseline.
**One week follow-up compared to baseline.
Table 5 CMR data in study population at baseline and
24 hr post marathon (n =25)
CMR parameters Pre marathon Post race
LV parameters
LVEDD (mm) 52 ± 3 51 ± 4
LVESD (mm) 31 ± 4 30 ± 5
LVEDV/BSA (ml/m2) 82 ± 9 84 ± 7
LVESV/BSA (ml/m2) 24 ± 8 26 ± 6
IVS (mm) 9 ± 1 9 ± 1
PWT (mm) 9 ± 2 9 ± 1
LVEF (%) 67 ± 4 69 ± 3
LV mass/ BSA (g/m2) 126 ± 14 123 ± 9
LA parameters
LA diameter (mm) 34 ± 4 36 ± 6
LA volume/ BSA (ml/m2) 26 ± 8 27 ± 4
RA and RV parameters
RA volume (ml) 39 ± 8 57 ± 10*
RVEDD (cm) 33 ± 5 47 ± 4*
RVEDV (ml) 133 ± 19 190 ± 18*
RVEF (%) 65 ± 3 44 ± 6*
RV mass/BSA (g/m2) 32 ± 4 34 ± 3
Data are expressed as mean ± SD. *p < 0.05, after the race vs. baseline.
CMR, cardiac magnetic resonance; LVEDD, LV end-diastolic diameter; LVESD,
LV end-systolic diameter; LVEDV, LV end-diastolic volume; LVESV,
LV end-systolic volume; IVS, interventricular septum; PWT, posterior wall
thickness; LVEF, LV ejection fraction; BSA, body surface area; LA, left atrium;
RA, right atrium; RVEDD, RV end-diastolic diameter; RVEDV, RV end-diastolic
volume; RVEF, RV ejection fraction.
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endurance running in older participants. In a 2009 study
by Knebel et al., 78 male marathon runners were evaluated
using both cardiac biomarker analysis and TTE [1]. The
study population was divided into older (>60 years; n = 23)
and younger (<60 years; n = 50) individuals. In the older
cohort, nearly 30% demonstrated an increase in cTnT and
N-terminal pro-brain natriuretic peptide (NT-proBNP) im-
mediately after the race, which normalized 2-weeks post
marathon [1]. In our study, all participants demonstratedFigure 1 A) Short axis phase sensitive IR-prepared T1-weighted Turbo
involving the anterior wall of the LV at baseline, prior to the maratho
angiogram in the same patient demonstrating a >70% stenosis of the LADan abnormal biochemical profile immediately after com-
pleting the marathon, confirming the findings of Knebel
et al [1]. They also demonstrated that TDI strain analysis
of the basal, mid and apical RV free wall using TTE
decreased after prolonged exercise in the older cohort, in-
dicative of RV functional impairment [1]. Using both TTE
and CMR, our study also confirms transient RV systolic
dysfunction due to exercise induced pulmonary hyperten-
sion in an older cohort of endurance athletes [1,19].
While there is significant agreement between studies
regarding the elevation of cardiac biomarkers immediately
post-marathon, its cause remains unclear [6-9,16,20-25].
LGE-CMR imaging is used routinely for the noninvasive
detection of myocardial fibrosis. The pattern of LGE allows
for the differentiation of CAD versus non-CAD etiologies
of myocardial scar formation. Four previous studies using
a younger cohort of marathon athletes demonstrated no
evidence of LGE of the LV myocardium, suggesting that
true myocardial necrosis does not occur [11,12,15,16]. Our
current study extends this understanding to an older co-
hort of individuals, whereby repeated endurance stress
does not seem to result in myocardial fibrosis in this pa-
tient population.
Recently, Breuckmann et al. demonstrated that marathon
participants exhibited LGE of the LV myocardium three
times more often than their age-matched controls [14].
They also noted different patterns of LGE within the mara-
thon participant group; 42% exhibited LGE typical of a
prior myocardial infarction, while the remaining 58%
exhibited LGE in an atypical pattern described as patchy or
streaky [14]. While a preceding history of IHD was an ex-
clusion factor for participation in their study [14], the pres-
ence of occult CAD was not systematically evaluated.
These findings were recently confirmed by a smaller study
by Wilson et al. who observed LGE in 6 of 12 elite veteran
athletes (57±6 years), but not in 17 younger (31±5 years)
athletes [26]. Although the LGE pattern was described in a
non-CAD pattern in 5 of these 6 older athletes, the under-
lying cause of this observation was not evaluated [26].FLASH MR image demonstrating subendocardial enhancement
n (arrows). B) Curved planar reformation of a contrast-enhanced CT
artery (arrow).
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ence of occult CAD using CCT as a potential cause of
myocardial fibrosis in marathon athletes over the age of 50.
Two individuals were clinically asymptomatic, but were
found to have LGE of the anterior wall of the LV myocar-
dium in a subendocardial distribution prior to running the
marathon, with concomitant evidence of obstructive LAD
disease. In a 2008 study by Mohlenkamp et al., recreational
marathon runners presenting with myocardial LGE were
found to have higher coronary artery calcification (CAC)
scores [2]. Their study findings supported a pathophysio-
logical link between epicardial subclinical plaque burden
and myocardial damage in marathon runners, increasing
our awareness of CAD in this patient population [2].
Although the presence of LGE of the myocardium in
older endurance marathoners may be due to underlying
CAD, the small number of individuals in our study does
not allow for any definitive conclusions. A larger patient
population from all ages with both CCT and CMR would
allow for defining the prevalence of silent CAD in mara-
thon participants. Future studies addressing the long-term
cardiovascular outcomes of athletes with incidental find-
ings of CAD and LGE are required.
Conclusion
Marathon running in individuals over the age of 50 is asso-
ciated with a transient, yet reversible increase in cardiac
biomarkers and RV systolic dysfunction. The presence of
myocardial fibrosis in older marathon athletes is infre-
quent, but when present, may be due to underlying occult
CAD. Larger studies are needed to confirm these findings.
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